Mavefund Subscribe

Investor profile

Scion Asset Management

Compact public equity portfolio disclosed through quarterly Form 13F filings.

Latest filing: Nov 3, 2025 Source: SEC 13F Research only
Daily return-1.0%
1Y return-9.6%
Drawdown-15.6%
Holdings8

Up to 10-Year Annual Return Study

Most recent complete calendar-year price return rows for the latest disclosed top-holdings basket compared with the S&P 500 benchmark. Current year is year to date.

2026 Jan 1, 2026 - Jul 29, 2026 100.0% mapped
Basket
-19.4%
S&P 500
+6.9%
2025 Jan 1, 2025 - Dec 31, 2025 100.0% mapped
Basket
+92.4%
S&P 500
+16.4%
2024 Jan 1, 2024 - Dec 31, 2024 100.0% mapped
Basket
+245.6%
S&P 500
+23.3%
2023 Jan 1, 2023 - Dec 31, 2023 100.0% mapped
Basket
+97.5%
S&P 500
+24.2%
2022 Jan 1, 2022 - Dec 31, 2022 100.0% mapped
Basket
-39.1%
S&P 500
-19.4%
2021 Jan 1, 2021 - Dec 31, 2021 100.0% mapped
Basket
-3.6%
S&P 500
+26.9%
2020 Jan 1, 2020 - Dec 31, 2020 34.0% mapped
Basket
+55.5%
S&P 500
+16.3%
2019 Jan 1, 2019 - Dec 31, 2019 34.0% mapped
Basket
+24.6%
S&P 500
+28.9%
2018 Jan 1, 2018 - Dec 31, 2018 34.0% mapped
Basket
-15.2%
S&P 500
-11.2%

Methodology: current latest disclosed 13F top holdings are price-marked through historical stock_price data and normalized to mapped tickers. Annual rows are refreshed by the tracker cron after market-close price data updates. Benchmark rows use S&P 500 marks from stock_price and fall back to mavefund_index_return annual S&P 500 rows when older price-table history is unavailable. This is a research backtest with survivorship bias, not the manager's actual fund return.

Basket Return Estimate

Indexed price mark of the latest disclosed holdings with mapped tickers.

Latest Disclosed Moves

New and increased positions are disclosed adds; reduced and exited positions are disclosed trims or exits versus the prior filing.

Nov 3, 2025 Exited
Scion Asset Management no longer disclosed a prior position

LAUDER ESTEE COS INC was not present in the latest 13F information table after a prior 2.10% disclosed weight.

Nov 3, 2025 Exited
Scion Asset Management no longer disclosed a prior position

ASML HOLDING N V was not present in the latest 13F information table after a prior 3.46% disclosed weight. ASML Holding NV

Major Winners

Largest positive one-year contribution from mapped current holdings.

Ticker Company 1Y return Weight Contribution
HAL Halliburton Company +41.4% 4.5% +1.8%
NVDA NVIDIA Corporation +8.9% 13.5% +1.2%
BRKR Bruker Corporation +57.3% 1.0% +0.5%
PFE Pfizer Inc +4.7% 11.1% +0.5%
MOH Molina Healthcare Inc +21.9% 1.7% +0.4%

Major Losses

Largest negative or weakest one-year contribution from mapped current holdings.

Ticker Company 1Y return Weight Contribution
PLTR Palantir Technologies Inc. -23.0% 66.0% -15.2%
LULU Lululemon Athletica Inc -42.1% 1.3% -0.5%
SLM SLM Corp -19.2% 1.0% -0.2%
MOH Molina Healthcare Inc +21.9% 1.7% +0.4%
PFE Pfizer Inc +4.7% 11.1% +0.5%

Latest Disclosed Holdings

Weights are based on the information table value in the latest imported filing.

Ticker Company Weight Shares Market value Sector
PLTR Palantir Technologies Inc.
CUSIP 69608A108
66.0% 5,000,000 912,100,000,000 Technology
NVDA NVIDIA Corporation
CUSIP 67066G104
13.5% 1,000,000 186,580,000,000 Technology
PFE Pfizer Inc
CUSIP 717081103
11.1% 6,000,000 152,880,000,000 Healthcare
HAL Halliburton Company
CUSIP 406216101
4.5% 2,500,000 61,500,000,000 Energy
MOH Molina Healthcare Inc
CUSIP 60855R100
1.7% 125,000 23,920,000,000 Healthcare
LULU Lululemon Athletica Inc
CUSIP 550021109
1.3% 100,000 17,793,000,000 Consumer Cyclical
SLM SLM Corp
CUSIP 78442P106
1.0% 480,054 13,287,895,000 Financial Services
BRKR Bruker Corporation
CUSIP 116794207
1.0% 48,334 13,137,181,000 Healthcare

Research and Risk Disclosure

This page is for informational research and decision support only. It is not personalized financial advice and does not say that any user should buy or sell a security. 13F investor data reflects last disclosed public filings and may be delayed, incomplete, amended, or no longer current. Strategy returns are historical model output or live tracking only when explicitly marked live. Review benchmark, time period, rebalancing frequency, data assumptions, fees, slippage, drawdown, and survivorship-bias handling before relying on any performance comparison.